956 related articles for article (PubMed ID: 28606510)
61. Enzyme Kinetics and Molecular Docking Studies on Cytochrome 2B6, 2C19, 2E1, and 3A4 Activities by Sauchinone.
Gong EC; Chea S; Balupuri A; Kang NS; Chin YW; Choi YH
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498658
[TBL] [Abstract][Full Text] [Related]
62. Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products.
Appiah-Opong R; Commandeur JN; van Vugt-Lussenburg B; Vermeulen NP
Toxicology; 2007 Jun; 235(1-2):83-91. PubMed ID: 17433521
[TBL] [Abstract][Full Text] [Related]
63. The impact of legacy and novel perfluoroalkyl substances on human cytochrome P450: An in vitro study on the inhibitory potential and underlying mechanisms.
Amstutz VH; Cengo A; Sijm DTHM; Vrolijk MF
Toxicology; 2022 Feb; 468():153116. PubMed ID: 35121066
[TBL] [Abstract][Full Text] [Related]
64. An automated cocktail method for in vitro assessment of direct and time-dependent inhibition of nine major cytochrome P450 enzymes - application to establishing CYP2C8 inhibitor selectivity.
Kahma H; Aurinsalo L; Neuvonen M; Katajamäki J; Paludetto MN; Viinamäki J; Launiainen T; Filppula AM; Tornio A; Niemi M; Backman JT
Eur J Pharm Sci; 2021 Jul; 162():105810. PubMed ID: 33753217
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids.
Salminen KA; Meyer A; Jerabkova L; Korhonen LE; Rahnasto M; Juvonen RO; Imming P; Raunio H
Phytomedicine; 2011 Apr; 18(6):533-8. PubMed ID: 20851588
[TBL] [Abstract][Full Text] [Related]
66. Use of Human Plasma Samples to Identify Circulating Drug Metabolites that Inhibit Cytochrome P450 Enzymes.
Eng H; Obach RS
Drug Metab Dispos; 2016 Aug; 44(8):1217-28. PubMed ID: 27271369
[TBL] [Abstract][Full Text] [Related]
67. In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450.
McCormick A; Swaisland H; Reddy VP; Learoyd M; Scarfe G
Xenobiotica; 2018 Jun; 48(6):555-564. PubMed ID: 28657402
[TBL] [Abstract][Full Text] [Related]
68. Mechanism-based inhibition of Alantolactone on human cytochrome P450 3A4 in vitro and activity of hepatic cytochrome P450 in mice.
Qin CZ; Lv QL; Wu NY; Cheng L; Chu YC; Chu TY; Hu L; Cheng Y; Zhang X; Zhou HH
J Ethnopharmacol; 2015 Jun; 168():146-9. PubMed ID: 25858508
[TBL] [Abstract][Full Text] [Related]
69. Investigation of CYP3A4 and CYP2D6 Interactions of Withania somnifera and Centella asiatica in Human Liver Microsomes.
Savai J; Varghese A; Pandita N; Chintamaneni M
Phytother Res; 2015 May; 29(5):785-90. PubMed ID: 25684704
[TBL] [Abstract][Full Text] [Related]
70. Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential.
Moody GC; Griffin SJ; Mather AN; McGinnity DF; Riley RJ
Xenobiotica; 1999 Jan; 29(1):53-75. PubMed ID: 10078840
[TBL] [Abstract][Full Text] [Related]
71. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
Obach RS
J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
[TBL] [Abstract][Full Text] [Related]
72. Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies.
Ericsson T; Sundell J; Torkelsson A; Hoffmann KJ; Ashton M
Xenobiotica; 2014 Jul; 44(7):615-26. PubMed ID: 24400699
[TBL] [Abstract][Full Text] [Related]
73. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes.
Kim JH; Kwon SS; Jeong HU; Lee HS
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468305
[TBL] [Abstract][Full Text] [Related]
74. In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters.
Kim S; Kim DK; Shin Y; Jeon JH; Song IS; Lee HS
Molecules; 2020 Oct; 25(19):. PubMed ID: 33050066
[TBL] [Abstract][Full Text] [Related]
75. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
[TBL] [Abstract][Full Text] [Related]
76. Searching the cytochrome p450 enzymes for the metabolism of meranzin hydrate: a prospective antidepressant originating from Chaihu-Shugan-San.
Huang X; Guo Y; Huang WH; Zhang W; Tan ZR; Peng JB; Wang YC; Hu DL; Ouyang DS; Xiao J; Wang Y; Luo M; Chen Y
PLoS One; 2014; 9(11):e113819. PubMed ID: 25427198
[TBL] [Abstract][Full Text] [Related]
77. Inhibitory effects of cedrol, β-cedrene, and thujopsene on cytochrome P450 enzyme activities in human liver microsomes.
Jeong HU; Kwon SS; Kong TY; Kim JH; Lee HS
J Toxicol Environ Health A; 2014; 77(22-24):1522-32. PubMed ID: 25343299
[TBL] [Abstract][Full Text] [Related]
78. Inhibitory effects of limonin on six human cytochrome P450 enzymes and P-glycoprotein in vitro.
Han YL; Yu HL; Li D; Meng XL; Zhou ZY; Yu Q; Zhang XY; Wang FJ; Guo C
Toxicol In Vitro; 2011 Dec; 25(8):1828-33. PubMed ID: 22001672
[TBL] [Abstract][Full Text] [Related]
79.
Zhang C; Li Y; Yin C; Zheng J; Liu G
Pharm Biol; 2021 Dec; 59(1):935-940. PubMed ID: 35294326
[TBL] [Abstract][Full Text] [Related]
80. Evaluation of in vitro cytochrome P450 induction and inhibition activity of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber L.
Koe XF; Lim EL; Seah TC; Amanah A; Wahab HA; Adenan MI; Sulaiman SF; Tan ML
Food Chem Toxicol; 2013 Oct; 60():98-108. PubMed ID: 23876819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]